MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$395,991
Net Income
-$1,883,290
Net Profit Margin
-475.59%
Unit: Dollar
Revenue Breakdown
Gross sales
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net sales
395,991
391,764
518,597*
425,864
Cost of sales
160,455
154,739
259,518.5*
171,401
Gross profit
235,536
237,025
259,078.5*
254,463
Selling and marketing
191,438
270,637
366,985*
358,535
Research and development
73,351
55,488
103,989.5*
227,993
General and administrative
681,559
1,224,354
1,871,374.5*
1,122,684
Depreciation and amortization of intangible assets
13,338
15,038
29,871*
16,268
Total operating expenses
959,686
1,565,517
2,372,220*
1,725,480
Loss from operations
-724,150
-1,328,492
-2,113,141.5*
-1,471,017
Other income
89
860
249,893*
7,299
Interest expense
-2,153
3,450
3,037*
5,059
Change in fair value of earnout liabilities
-55,996
-96,053
108,728*
-86,104
Inventory write-down
38,917
196,684
-80,283*
47,082
Amortization of debt discount
-
-
0*
0
Loss on forward purchase agreement
-
-
0*
0
Loss on lease termination
-
-
0*
0
Loss on litigation settlement
-1,174,155
-
-
-
Total other income (expense)
-1,159,140
-103,221
218,411*
41,262
Loss from operations before income taxes
-1,883,290
-1,431,713
-1,894,730.5*
-1,429,755
Income tax expense
0
0
36,262*
0
Loss from continuing operations
-
-
-1,930,992.5*
-1,429,755
Loss from discontinued operations, net of tax
-
-
0*
0
Gain on sale of discontinued operations
-
-
0*
0
Net loss
-1,883,290
-1,431,713
-1,930,992.5
-1,429,755
Basic EPS
-0.76
-0.75
-1.425
-0.83
Diluted EPS
-
-0.75
-1.425
-0.83
Basic Average Shares
2,475,321
1,899,910
1,355,428
1,723,434
Diluted Average Shares
-
1,899,910
1,355,428
1,723,434
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,883,290
(0.17%↑ Y/Y)
Gross sales
$444,967
(-16.98%↓ Y/Y)
Loss from operations
before income taxes
-$1,883,290
(0.17%↑ Y/Y)
Net sales
$395,991
(-21.37%↓ Y/Y)
Discounts and allowances
-$48,976
(-51.32%↓ Y/Y)
Total other income
(expense)
-$1,159,140
(-4064.48%↓ Y/Y)
Loss from operations
-$724,150
(61.04%↑ Y/Y)
Change in fair value of
earnout liabilities
-$55,996
(-288.98%↓ Y/Y)
Gross profit
$235,536
(-22.18%↓ Y/Y)
Other income
$89
(-97.96%↓ Y/Y)
Cost of sales
$160,455
(-20.15%↓ Y/Y)
Loss on litigation
settlement
-$1,174,155
Total operating
expenses
$959,686
(-55.60%↓ Y/Y)
Inventory write-down
$38,917
Interest expense
-$2,153
(-184.07%↓ Y/Y)
General and
administrative
$681,559
(-56.45%↓ Y/Y)
Selling and marketing
$191,438
(-44.59%↓ Y/Y)
Research and development
$73,351
(-67.91%↓ Y/Y)
Depreciation and
amortization of intangible...
$13,338
(-39.88%↓ Y/Y)
Buy us a coffee
Longevity Health Holdings, Inc. (XAGEW)
Longevity Health Holdings, Inc. (XAGEW)